Knapen, R. R. M. M. http://orcid.org/0000-0003-4677-3685
Celen, M.
Pinckaers, F. M. E.
Wagemans, B. A. J. M.
van Zwam, W. H.
van Oostenbrugge, R. J.
van der Leij, C.
Article History
Received: 7 December 2023
Accepted: 23 March 2024
First Online: 19 April 2024
Change Date: 7 May 2024
Change Type: Update
Change Details: This article was updated to correct Ischem to Ishemic in the title.
Declarations
:
: WHvZ reports speaker fees from Stryker, Cerenovus, and Nicolab, and consulting fees from Philips (all paid to institution); participated in the advisory boards of WeTrust (Philips) and ANAIS (Anaconda) (all paid to institution); and participated in the advisory boards of InEcxtremis (CHU Montpellier, Montpellier, France) and DISTAL (University Hospital Basel, Basel, Switzerland), studies for which no payments were received. All other authors declare no competing interests.
: For this type of study, formal consent is not required.
: For this type of study, consent for publication is not required.
: This study has obtained IRB approval from ‘METC azM/UM’ (Medical ethical Review Board), protocol number (METC 2022-3398), and the need for informed consent was waived.